Portfolio

DRI Capital, through its managed funds, has purchased royalties from some of the world’s leading pharmaceutical and biotechnology companies, research institutions, universities and inventors.

As a result of these transactions, DRI Capital, through its managed funds, owns royalties on some of the best selling biopharmaceutical products in the world.